세계 1차 세포 배양 시장 조사 보고서 : 산업 분석, 규모, 점유율, 성장 및 동향 예측(2024-2032년)
Global Primary Cell Culture Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
상품코드:1448625
리서치사:Value Market Research
발행일:2024년 02월
페이지 정보:영문 291 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
1차 세포 배양 시장의 세계 수요는 2023년의 52억 3,000만 달러에서 2032년에는 174억 1,000만 달러 근처 시장 규모에 이를 것으로 추정되며, 조사 기간 2024-2032년의 CAGR은 14.3%입니다.
1차 세포 배양은 연구 및 치료 목적을 위해 유기체로부터 직접 추출한 세포를 자연 환경을 유지하고 배양하는 것을 포함합니다. 이 기술은 생물학과 의학 연구에서 매우 중요하며, 과학자들은 세포의 거동을 연구하고, 약물 시험을 실시하고, 맞춤형 의료를 개발할 수 있습니다.
시장 역학
1차 세포 배양 시장은 맞춤형 의료에 대한 관심 증가, 세포 기반 연구의 진보, 세포 기반 치료에 대한 수요 증가 등의 요인에 의해 견인되고 있습니다. 생물체에서 직접 유래된 이러한 세포 배양물은 세포의 거동을 연구하고 새로운 치료법을 개발하기 위한 귀중한 모델로 유용합니다. 재생 의학의 확대와 표적 요법의 개발은 전임상 연구와 창약에서 1차 세포 배양에 대한 수요를 부추깁니다. 게다가 만성 질환의 유병률 증가와 더 정확한 in vitro 모델의 필요성은 시장 성장에 기여하고 있습니다. 3D 세포 배양 시스템 및 오가노이드와 같은 기술 혁신은 생물 의학 연구에서 관련성과 유용성을 더욱 향상시키고 있습니다. 게다가 연구기관과 생명공학기업의 공동연구가 1차세포 배양기술의 진보를 촉진하여 시장의 궤도를 형성하고 있습니다.
이 조사 보고서는 Porter's Five Forces 모델, 시장 매력 분석, 밸류체인 분석을 다룹니다. 이러한 도구는 업계의 구조를 명확하게 파악하고 세계 수준에서 경쟁의 매력을 평가하는 데 도움이 됩니다. 게다가, 이러한 도구는 또한 1차 세포 배양 세계 시장에서 각 부문을 종합적으로 평가할 수 있습니다. 1 차 세포 배양 산업의 성장과 동향은이 연구에 전반적인 접근을 제공합니다.
시장 세분화
1차 세포 배양 시장 세분화를 통해 국가별 및 지역별 부문에 대한 자세한 데이터를 제공함으로써 전략 담당자가 각 제품 및 서비스의 대상 계층을 파악하고 향후 비즈니스 기회에 도움을 줄 수 있습니다.
The global demand for Primary Cell Culture Market is presumed to reach the market size of nearly USD 17.41 BN by 2032 from USD 5.23 BN in 2023 with a CAGR of 14.3% under the study period 2024 - 2032.
Primary cell culture involves the cultivation of cells directly extracted from living organisms, maintaining their natural environment for research and therapeutic purposes. This technique is crucial in biological and medical research, enabling scientists to study cell behavior, perform drug testing, and develop personalized medicine.
MARKET DYNAMICS
The primary cell culture market is driven by factors such as the increasing focus on personalized medicine, advancements in cell-based research, and the rising demand for cell-based therapies. These cell cultures, derived directly from living organisms, serve as valuable models for studying cellular behavior and developing novel medical treatments. The expansion of regenerative medicine and the development of targeted therapies fuel the demand for primary cell cultures in preclinical research and drug discovery. Additionally, the growing prevalence of chronic diseases and the need for more accurate in vitro models contribute to market growth. Technological innovations, including 3D cell culture systems and organoids, further enhance its relevance and utility in biomedical research. Moreover, collaborations between research institutions and biotechnology companies drive advancements in primary cell culture technologies, shaping the market's trajectory.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of primary cell culture. The growth and trends of primary cell culture industry provide a holistic approach to this study.
MARKET SEGMENTATION
This section of the primary cell culture market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
This section covers the regional outlook, which accentuates current and future demand for the Primary Cell Culture market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Primary Cell Culture market include Merck, Thermo Fisher Scientific Inc., Danaher, Lonza, PromoCell GmbH, Corning Incorporated, Fujifilm Irvine Scientific Inc., Mattek, Axol Bioscience Ltd., ATCC. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.
3.7.2 Market Attractiveness Analysis By Separation Method
3.7.3 Market Attractiveness Analysis By Type
3.7.4 Market Attractiveness Analysis By Application
3.7.5 Market Attractiveness Analysis By Region
4 . VALUE CHAIN ANALYSIS
4.1. Value Chain Analysis
4.2. Raw Material Analysis
4.2.1. List of Raw Materials
4.2.2. Raw Material Manufactures List
4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
4.4.1. Direct Marketing
4.4.2. Indirect Marketing
4.4.3. Marketing Channel Development Trend
5 . GLOBAL PRIMARY CELL CULTURE MARKET ANALYSIS BY PRODUCT
5.1 Overview by Product
5.2 Historical and Forecast Data
5.3 Analysis by Product
5.4 Primary Cells (Fat Cells, Blood Cells, Nerve Cells, Bone Cells, Endothelial Cells, Skin Cells, Muscle Cells, Stem Cells, Others) Historic and Forecast Sales by Regions
5.5 Reagents And Supplements (Attachment Solutions, Buffers And Salts, Sera, Growth Factors And Cytokines, Others) Historic and Forecast Sales by Regions
5.6 Media (Fat Cells Media, Blood Cells Media, Nerve Cells Media, Bone Cells Media, Endothelial Cells Media, Skin Cells Media, Muscle Cells Media, Stem Cells Media, Others) Historic and Forecast Sales by Regions
6 . GLOBAL PRIMARY CELL CULTURE MARKET ANALYSIS BY SEPARATION METHOD
6.1 Overview by Separation Method
6.2 Historical and Forecast Data
6.3 Analysis by Separation Method
6.4 Explant Method Historic and Forecast Sales by Regions
6.5 Enzymatic Degradation (Trypsin, Collagenase, Protease, Pronase, Dispase, Hyaluronidase, Neuraminidase, Elastase, Dnase, Papain, Accutase, Others) Historic and Forecast Sales by Regions
6.6 Mechanical Separation Historic and Forecast Sales by Regions
6.7 Others Historic and Forecast Sales by Regions
7 . GLOBAL PRIMARY CELL CULTURE MARKET ANALYSIS BY TYPE
7.1 Overview by Type
7.2 Historical and Forecast Data
7.3 Analysis by Type
7.4 Animal Cells Historic and Forecast Sales by Regions
7.5 Human Cells Historic and Forecast Sales by Regions
8 . GLOBAL PRIMARY CELL CULTURE MARKET ANALYSIS BY APPLICATION
8.1 Overview by Application
8.2 Historical and Forecast Data
8.3 Analysis by Application
8.4 Cell & Gene Therapy Development Historic and Forecast Sales by Regions
8.5 Vaccine Production Historic and Forecast Sales by Regions
8.6 Model System Historic and Forecast Sales by Regions
8.7 Virology Historic and Forecast Sales by Regions
8.8 Prenatal Diagnosis Historic and Forecast Sales by Regions
8.9 Others Historic and Forecast Sales by Regions
9 . GLOBAL PRIMARY CELL CULTURE MARKET ANALYSIS BY GEOGRAPHY
9.1. Regional Outlook
9.2. Introduction
9.3. North America Sales Analysis
9.3.1. Overview, Historic and Forecast Data Sales Analysis
9.3.2. North America By Segment Sales Analysis
9.3.3. North America By Country Sales Analysis
9.3.4. United State Sales Analysis
9.3.5. Canada Sales Analysis
9.3.6. Mexico Sales Analysis
9.4. Europe Sales Analysis
9.4.1. Overview, Historic and Forecast Data Sales Analysis
9.4.2. Europe by Segment Sales Analysis
9.4.3. Europe by Country Sales Analysis
9.4.4. United Kingdom Sales Analysis
9.4.5. France Sales Analysis
9.4.6. Germany Sales Analysis
9.4.7. Italy Sales Analysis
9.4.8. Russia Sales Analysis
9.4.9. Rest Of Europe Sales Analysis
9.5. Asia Pacific Sales Analysis
9.5.1. Overview, Historic and Forecast Data Sales Analysis
9.5.2. Asia Pacific by Segment Sales Analysis
9.5.3. Asia Pacific by Country Sales Analysis
9.5.4. China Sales Analysis
9.5.5. India Sales Analysis
9.5.6. Japan Sales Analysis
9.5.7. South Korea Sales Analysis
9.5.8. Australia Sales Analysis
9.5.9. South East Asia Sales Analysis
9.5.10. Rest Of Asia Pacific Sales Analysis
9.6. Latin America Sales Analysis
9.6.1. Overview, Historic and Forecast Data Sales Analysis
9.6.2. Latin America by Segment Sales Analysis
9.6.3. Latin America by Country Sales Analysis
9.6.4. Brazil Sales Analysis
9.6.5. Argentina Sales Analysis
9.6.6. Peru Sales Analysis
9.6.7. Chile Sales Analysis
9.6.8. Rest of Latin America Sales Analysis
9.7. Middle East & Africa Sales Analysis
9.7.1. Overview, Historic and Forecast Data Sales Analysis
9.7.2. Middle East & Africa by Segment Sales Analysis
9.7.3. Middle East & Africa by Country Sales Analysis
9.7.4. Saudi Arabia Sales Analysis
9.7.5. UAE Sales Analysis
9.7.6. Israel Sales Analysis
9.7.7. South Africa Sales Analysis
9.7.8. Rest Of Middle East And Africa Sales Analysis
10 . COMPETITIVE LANDSCAPE OF THE PRIMARY CELL CULTURE COMPANIES
10.1. Primary Cell Culture Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments
11 . COMPANY PROFILES OF PRIMARY CELL CULTURE INDUSTRY
11.1. Company Share Analysis
11.2. Market Concentration Rate
11.3. Merck
11.3.1. Company Overview
11.3.2. Company Revenue
11.3.3. Products
11.3.4. Recent Developments
11.4. Thermo Fisher Scientific Inc.
11.4.1. Company Overview
11.4.2. Company Revenue
11.4.3. Products
11.4.4. Recent Developments
11.5. Danaher
11.5.1. Company Overview
11.5.2. Company Revenue
11.5.3. Products
11.5.4. Recent Developments
11.6. Lonza
11.6.1. Company Overview
11.6.2. Company Revenue
11.6.3. Products
11.6.4. Recent Developments
11.7. PromoCell GmbH
11.7.1. Company Overview
11.7.2. Company Revenue
11.7.3. Products
11.7.4. Recent Developments
11.8. Corning Incorporated
11.8.1. Company Overview
11.8.2. Company Revenue
11.8.3. Products
11.8.4. Recent Developments
11.9. Fujifilm Irvine Scientific Inc.
11.9.1. Company Overview
11.9.2. Company Revenue
11.9.3. Products
11.9.4. Recent Developments
11.10. Mattek
11.10.1. Company Overview
11.10.2. Company Revenue
11.10.3. Products
11.10.4. Recent Developments
11.11. Axol Bioscience Ltd.
11.11.1. Company Overview
11.11.2. Company Revenue
11.11.3. Products
11.11.4. Recent Developments
11.12. ATCC.
11.12.1. Company Overview
11.12.2. Company Revenue
11.12.3. Products
11.12.4. Recent Developments
Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
